These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 16956949)

  • 21. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation.
    Vázquez N; Greenwell-Wild T; Marinos NJ; Swaim WD; Nares S; Ott DE; Schubert U; Henklein P; Orenstein JM; Sporn MB; Wahl SM
    J Virol; 2005 Apr; 79(7):4479-91. PubMed ID: 15767448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA.
    Poon B; Chen IS
    J Virol; 2003 Apr; 77(7):3962-72. PubMed ID: 12634356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
    Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
    DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.
    Zhou T; Dang Y; Baker JJ; Zhou J; Zheng YH
    Retrovirology; 2012 Nov; 9():93. PubMed ID: 23134572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1.
    Li G; Elder RT; Qin K; Park HU; Liang D; Zhao RY
    J Biol Chem; 2007 Mar; 282(10):7287-98. PubMed ID: 17210576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
    Azad AA
    Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the biology of HIV-1 viral protein R.
    Sherman MP; De Noronha CM; Williams SA; Greene WC
    DNA Cell Biol; 2002 Sep; 21(9):679-88. PubMed ID: 12396611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
    Connor RI; Chen BK; Choe S; Landau NR
    Virology; 1995 Feb; 206(2):935-44. PubMed ID: 7531918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 Vpr: G2 cell cycle arrest, macrophages and nuclear transport.
    Re F; Luban J
    Prog Cell Cycle Res; 1997; 3():21-7. PubMed ID: 9552403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vpr stimulates viral expression and induces cell killing in human immunodeficiency virus type 1-infected dividing Jurkat T cells.
    Yao XJ; Mouland AJ; Subbramanian RA; Forget J; Rougeau N; Bergeron D; Cohen EA
    J Virol; 1998 Jun; 72(6):4686-93. PubMed ID: 9573232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.
    Belzile JP; Richard J; Rougeau N; Xiao Y; Cohen EA
    J Virol; 2010 Apr; 84(7):3320-30. PubMed ID: 20089662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell-mediated killing.
    Richard J; Sindhu S; Pham TN; Belzile JP; Cohen EA
    Blood; 2010 Feb; 115(7):1354-63. PubMed ID: 20008788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr.
    Shen A; Siliciano JD; Pierson TC; Buck CB; Siliciano RF
    Virology; 2000 Dec; 278(1):227-33. PubMed ID: 11112497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway.
    Vassena L; Giuliani E; Matusali G; Cohen ÉA; Doria M
    J Gen Virol; 2013 Dec; 94(Pt 12):2664-2669. PubMed ID: 24045107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection.
    Hrimech M; Yao XJ; Bachand F; Rougeau N; Cohen EA
    J Virol; 1999 May; 73(5):4101-9. PubMed ID: 10196306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination.
    Nakai-Murakami C; Shimura M; Kinomoto M; Takizawa Y; Tokunaga K; Taguchi T; Hoshino S; Miyagawa K; Sata T; Kurumizaka H; Yuo A; Ishizaka Y
    Oncogene; 2007 Jan; 26(4):477-86. PubMed ID: 16983346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human immunodeficiency virus type 1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.
    Huard S; Elder RT; Liang D; Li G; Zhao RY
    J Virol; 2008 Mar; 82(6):2904-17. PubMed ID: 18160429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.
    Bartz SR; Rogel ME; Emerman M
    J Virol; 1996 Apr; 70(4):2324-31. PubMed ID: 8642659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
    Forget J; Yao XJ; Mercier J; Cohen EA
    J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines.
    Gummuluru S; Emerman M
    J Virol; 1999 Jul; 73(7):5422-30. PubMed ID: 10364289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.